Clinical Trial Update: A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D. [Phase 3]

View source ↗

Summary

Phase 3 trial update on Pegasys alone or with Tenofovir for chronic hepatitis D has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Tenofovir (Tenofovir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis D, Chronic | Phase 3 | Status: COMPLETED